Zyprexa litigation has been targeted at a number of Zyprexa side-effect problems: Some
patients have reported the Zyprexa side-effect of gaining up to 65 pounds after taking Zyprexa.
After the weight gain some developed the Zyprexa side-effect of diabetes or glucose abnormalities.
Patients who already had the Zyprexa side-effect of theit diabetes growing worse while taking Zyprexa. Worse
yet -- patients died from developing diabetes. These patients were never
treated for diabetes and didnít know they had diabetes. Patients under
54 years old, face the highest risk of developing the Zyprexa side-effect of diabetes or having
heart attacks and comas when taking Zyprexa.
Have you, a family member, or dear friend been diagnosed with diabetes,
diabetic ketoacidosis, hyperglycemia, pancreatitis, or diabetic-induced
heart attack or coma following the use of Zyprexa? You may want to consider Zyprexa litigation
and may want to consult with a lawyer familiar with Zyprexa litigation. If so, please complete the
FREE no obligation consultation today.
Researchers have linked Zyprexa to the side-effect of onset of diabetes, hyperglycemia,
and neuroleptic malignant syndrome thereby creating enough concern and
patient outcry to lead Japan, Europe, and most recently the United
States to include warnings about the chronic side-effects and the sometimes-fatal Zyprexa
side-effect. (Japan published safety warnings two years before the
U.S.) Consumer groups believe that the FDA had done too little too late
to warn doctors and patients about the risks of hyperglycemia, diabetes,
ketoacidosis, heart attack, and coma from taking Zyprexa.
In November 2001, the Journal of the American Medical Association, the
FDA's Center for Drug Evaluation and Research, and a Duke University
Medical Center physician first possibly linked between the Zyprexa side-effect of
hyperglycemia in adolescents with the drug. FDA staff members published a report
in the December 2001 American Journal of Medicine linking Zyprexa to
diabetes. Both Zyprexa reports used information from the FDA's adverse
drug reaction database.
Most recently, the FDA has identified at least 384 reports of diabetes
linked to Zyprexa, with the majority of cases appearing within six
months of starting Zyprexa treatment. This has been a major focus in the Zyprexa litigation.
Consumer advocates claim that the Zyprexa side-effect warnings
referencing diabetes, heart attack, coma, and hyperglycemia are buried
deep within the adverse reactions section of the drugís labeling.
Patients are less likely to notice the warning when itís buried in the
smallest of fine print than if it were more prominently displayed. The failure to give adequate warnings is one of the core allegations in the Zyprexa litigation.
Researchers have also found preliminary evidence that linked the Zyprexa side-effect and
pancreatitis, a dangerous inflammation of the pancreas. Studies looked
at patients using four antipsychotic drugs and examined all the
pancreatitis cases reported to the FDA or written up in medical journals
between January 1981 and February 2002. Researchers found more instances
of pancreatitis in Clozaril, Zyprexa, and Risperdal patients.
Of the 192 Zyprexa side-effect cases, people using Zyprexa alone had 62 instances within the
four antipsychotic drugs. The pancreatitis occurrences resulted in 22
deaths. A definitive link between Zyprexa side-effect and pancreatitis has not yet
been established though the findings have raised concern.
Adding to the complexity surrounding the potential Zyprexa side-effect of the drug
is the strong connection between diabetes and schizophrenia, noted by
scientists since the 1920s. Sufferers of the debilitating brain disorder
develop diabetes at a rate up to four times higher than the general
population, whether they use antipsychotic drugs or not. People with
schizophrenia often lead a sedentary lifestyle, lack good medical care,
have poor diets, and high rates of obesity -- all which are risk factors
Eli Lilly has argued that Zyprexa's safety is supported by two Eli Lilly
sponsored studies. According to the manufacturer, two studies
demonstrate that Zyprexa has no diabetes-inducing effects. According to
doctors at the diabetes care center at the University of North Carolina,
too few patients were studied to detect a less common Zyprexa side